Factor XII gene mutation in the Hageman family

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 11, 2011, Pages 2329-2331

  Xu Cai, Y O ^a   Shen, J ^a   Chen, S ^a   Zhou, Y ^b   Larusch, G A ^c   Stavrou, E ^c   Schmaier, A H ^c   Wu, Q ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12;

ALLELE; ANGIOGENESIS; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; BLOOD VESSEL PERMEABILITY; COMPLEMENT ACTIVATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; GENE MUTATION; HUMAN; IMMUNOBLOTTING; LETTER; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; BIOCHEMISTRY; BIOMEDICAL RESEARCH; BLOOD COAGULATION; BLOOD PLATELETS; FACTOR XII; HUMANS; POLYPHOSPHATES;

EID: 80055104672     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04508.x     Document Type: Letter

References (17)

1. Ratnoff OD. The George M. Kober lecture. The legacy of John Hageman: new dividends. Trans Assoc Am Physicians 1985; 98: cli-clxi.
2. Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest 1955; 34: 602-13.
3. Davie EW. A brief historical review of the waterfall/cascade of blood coagulation. J Biol Chem 2003; 278: 50819-32.
4. Ratnoff OD, Davie EW. The purification of activated Hageman factor (activated factor XII). Biochemistry 1962; 1: 967-75.
5. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310-2.
6. Macfarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202: 498-9.
7. Ratnoff OD, Busse RJ, Sheon RP. The demise of John Hageman. N Engl J Med 1968; 279: 760-1.
8. Cool DE, MacGillivray RT. Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region. J Biol Chem 1987; 262: 13662-73.
9. Schloesser M, Hofferbert S, Bartz U, Lutze G, Lammle B, Engel W. The novel acceptor splice site mutation 11396(G->A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patients. Hum Mol Genet 1995; 4: 1235-7.
10. Schloesser M, Zeerleder S, Lutze G, Halbmayer WM, Hofferbert S, Hinney B, Koestering H, Lammle B, Pindur G, Thies K, Kohler M, Engel W. Mutations in the human factor XII gene. Blood 1997; 90: 3967-77.
11. Caen J, Wu Q. Hageman factor, platelets and polyphosphates: early history and recent connection. J Thromb Haemost 2010; 8: 1670-4.
12. Roberts HR. Oscar Ratnoff: his contributions to the golden era of coagulation research. Br J Haematol 2003; 122: 180-92.
13. Saito H, Matsushita T, Kojima T. Historical perspective and future direction of coagulation research. J Thromb Haemost 2011; 9(Suppl 1): 352-63.
14. Schmaier AH. Oscar D. Ratnoff: a man for all seasons. Thromb Haemost 2010; 104: 863-6.
15. Gailani D, Renne T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 2007; 27: 2507-13.
16. LaRusch GA, Mahdi F, Shariat-Madar Z, Adams G, Sitrin RG, Zhang WM, McCrae KR, Schmaier AH. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis. Blood 2010; 115: 5111-20.
17. Sainz IM, Pixley RA, Colman RW. Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology. Thromb Haemost 2007; 98: 77-83.